Institut National de la Sante et de la Recherche Medicale (INSERM);Centre National de la Recherche Scientifique (CNRS);Universite Paris Diderot Paris 7;Institut National Transfusion Sanguine
发明人:
Arnaud Chene,Benoit Gamain,Stéphane Gangnard
申请号：
US16061807
公开号：
US20180360950A1
申请日:
2016.12.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention generally relates to an immunogenic construct,useful for redirecting an EBV-existing immune response towards an undesired target cell and/or microorganism, to methods for preparing said conjugate, to a pharmaceutical applications comprising said conjugate, and to medical applications thereof.
